CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment-Reference-Cited by-同舟云学术

CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment

Published:2022-08-29 Issue:1 Volume:11 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Lecoq Inés¹²^ORCID,Kopp Katharina L.¹^ORCID,Chapellier Marion¹^ORCID,Mantas Panagiotis³^ORCID,Martinenaite Evelina¹²^ORCID,Perez-Penco Maria²^ORCID,Rønn Olsen Lars³^ORCID,Zocca Mai-Britt¹^ORCID,Wakatsuki Pedersen Ayako¹^ORCID,Andersen Mads Hald²⁴^ORCID

Affiliation:

1. Department of Research and Development, IO Biotech ApS, Copenhagen, Denmark

2. National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

3. Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark

4. Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark

Funder

Innovationsfonden

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link